Jun Min
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jun Min has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Chang-Zhen Shang
The ‖Department of General Surgery, General Hospital of Guangzhou Military Command of the People's Liberation Army, Guangzhou 510010, China
1 shared publicationChangzhen Shang
Department of Hepatology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou. 510120, China
1 shared publicationGuo-Lin Li
The ‖Department of General Surgery, General Hospital of Guangzhou Military Command of the People's Liberation Army, Guangzhou 510010, China
1 shared publicationGuojuan Lao
Department of Endocrinology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou. 510120, China
1 shared publicationHao-Ming Lin
The ‖Department of General Surgery, General Hospital of Guangzhou Military Command of the People's Liberation Army, Guangzhou 510010, China
1 shared publicationHua Cheng
Department of Endocrinology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou. 510120, China
1 shared publication
Latest Publications
- Open Access
- 17 December 2014
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 7586
Insulin-producing cells from embryonic stem cells rescues hyperglycemia via intra-spleen migration
Implantation of embryonic stem cells (ESC)-derived insulin-producing cells has been extensively investigated for treatment of diabetes in animal models. However, the in vivo behavior and migration of transplanted cells in diabetic models remains unclear. Here we investigated the location and migration of insulin-producing cells labeled with superparamagnetic iron oxide (SPIO) using a dynamic MRI tracking method. SPIO labeled cells showed hypointense signal under the kidney subcapsules of diabetic mice on MRI, and faded gradually over the visiting time. However, new hypointense signal appeared in the spleen 1 week after transplantation, and became obvious with the time prolongation. Further histological examination proved the immigrated cells were insulin and C-peptide positive cells which were evenly distributed throughout the spleen. These intra-spleen insulin-producing cells maintained their protective effects against hyperglycemia in vivo, and these effects were reversed upon spleen removal. Transplantation of insulin-producing cells through spleen acquired an earlier blood glucose control as compared with that through kidney subcapsules. In summary, our data demonstrate that insulin-producing cells transplanted through kidney subcapsules were not located in situ but migrated into spleen, and rescues hyperglycemia in diabetic models. MRI may provide a novel tracking method for preclinical cell transplantation therapy of diabetes continuously and non-invasively.
- 17 December 2014
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 7586
Open AccessInsulin-producing cells from embryonic stem cells rescues hyperglycemia via intra-spleen migration
Implantation of embryonic stem cells (ESC)-derived insulin-producing cells has been extensively investigated for treatment of diabetes in animal models. However, the in vivo behavior and migration of transplanted cells in diabetic models remains unclear. Here we investigated the location and migration of insulin-producing cells labeled with superparamagnetic iron oxide (SPIO) using a dynamic MRI tracking method. SPIO labeled cells showed hypointense signal under the kidney subcapsules of diabetic mice on MRI, and faded gradually over the visiting time. However, new hypointense signal appeared in the spleen 1 week after transplantation, and became obvious with the time prolongation. Further histological examination proved the immigrated cells were insulin and C-peptide positive cells which were evenly distributed throughout the spleen. These intra-spleen insulin-producing cells maintained their protective effects against hyperglycemia in vivo, and these effects were reversed upon spleen removal. Transplantation of insulin-producing cells through spleen acquired an earlier blood glucose control as compared with that through kidney subcapsules. In summary, our data demonstrate that insulin-producing cells transplanted through kidney subcapsules were not located in situ but migrated into spleen, and rescues hyperglycemia in diabetic models. MRI may provide a novel tracking method for preclinical cell transplantation therapy of diabetes continuously and non-invasively.
- Open Access
- 1 May 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (19) , 15874-15885
Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro
- 1 May 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (19) , 15874-15885
Open AccessAnticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro